{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-26-000243","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2026-11-10T21:43:30+00:00","discovered_at":"2026-11-10T21:44:00.214845+00:00","generated_at":"2026-11-10T21:44:05.074294+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"KORU Medical Q3 revenue $11.6M, up 11%; net income $0.2M, second straight positive quarter","bullets":["Net revenues $11.57M (+11.2% YoY); gross margin 65.2% vs 60.2%; gross profit $7.5M (+20.5%).","Domestic core revenue $8.06M (+31.6%); international core $3.08M (-16.5%); pharma services $0.42M (-27.4%).","Net income $0.2M ($0.00 diluted) vs prior-year net loss of $0.8M (-$0.02); adjusted EBITDA $1.3M vs $0.1M.","FY2026 revenue guidance narrowed to $48.0-48.5M (17-18% growth) from $47.5-48.5M; gross margin raised to 63-64%.","Signed two new sales and distribution agreements in Europe and Africa; year-end cash guidance raised to >$8.0M from >$7.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-26-000243","json":"https://secwatch.observer/filing/0001161697-26-000243.json","markdown":"https://secwatch.observer/filing/0001161697-26-000243.md","text":"https://secwatch.observer/filing/0001161697-26-000243.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/0001161697-26-000243-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169726000243/form_8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-10T21:44:05.074294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}